Scores of virtual events are afoot around the world to mark Rare Disease Day 2021 on Feb. 28. The…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
International Epilepsy Day (IED), falling on Feb. 8 this year, calls attention to the needs of the roughly 50 million…
While progress was made last year on newborn screening and other policy issues critical to rare disease patients, a “…
Caring for a loved one with a rare disease, especially during these uncertain times, demands significant time, attention, patience, and…
The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to…
After some 59 years, the chief drug policy-making entity of the United Nations (UN) has voted to remove cannabis from…
To empower and equip members of the rare disease community to engage state leaders in matters of importance to patients…
While Dravet syndrome patients don’t appear to be at increased risk of severe COVID-19 complications, more study is…
Dravet syndrome now has its own global health statistics codes — known as “ICD-10” codes — that potentially could…
A photo of a bespectacled young boy, his red baseball cap slightly askew as he  enjoys time outside, will be…